Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

Abridge vs Neuralink: Valuation, Funding, Trajectory

Health Both private US-headquartered No Canborsa market

This comparison puts Abridge next to Neuralink within health on size, funding and trajectory.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
AbridgePRIVATE · US
NeuralinkPRIVATE · US
VS
Last valuation$5.3B$9B
Basis Post-money Post-money
As ofApr 2026Jun 2025
Founded20182016
Employees≈200≈300
On CanborsaNo marketNo market
At a glance
$5.3B
AbridgePost-money, Series E extension · Apr 2026
$9B
NeuralinkPost-money, Series E · Jun 2025
1.70×
GapBoth post-money, 10 months apart
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

Abridge vs Neuralink — side by side

Field
AbridgePRIVATE · FOUNDED 2018
NeuralinkPRIVATE · FOUNDED 2016
VS
Last valuation
$5.3B Post-money
$9B Post-money
Valuation date
1 Apr 2026
1 Jun 2025
Valuation basis
Post-money
Post-money
Latest round
Series E extension
Series E
Round size
$316M
$650M
Round lead
Andreessen Horowitz, Khosla Ventures
ARK Invest, Sequoia Capital
Named investors
Andreessen Horowitz IVP Elad Gil Lightspeed Venture Partners
ARK Invest Sequoia Capital Founders Fund Thrive Capital
Founded
2018
2016
Employees (est.)
≈200
≈300
Sector & HQ
Healthcare technology and AI (AI-powered clinical documentation) · 🇺🇸 US
Neurotechnology / medical devices · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $5.3B for Abridge (post-money, Apr 2026) and $9B for Neuralink (post-money, Jun 2025).

Abridge
$5.3BPost-money · Apr 2026
Neuralink
$9BPost-money · Jun 2025
ABRIDGE · $5.3B · APR 2026NEURALINK · $9B · JUN 2025
Abridge vs Neuralink · what each company discloses

What each company discloses, and what it leaves out

AbridgePRIVATEHealth · US · 2018
+Last disclosed mark $5.3B — post-money, Apr 2026.
+Founded 2018 .
+≈200 employees.
+Latest round: Series E extension, $316M raised, led by Andreessen Horowitz.
NeuralinkPRIVATEHealth · US · 2016
+Last disclosed mark $9B — post-money, Jun 2025.
+Founded 2016 .
+≈300 employees.
+Latest round: Series E, $650M raised, led by ARK Invest.
Verdict

Verdict

The $5.3B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$316M, led by Andreessen Horowitz in Apr 2026.
A dated print: it moves only when a newer round is announced.
The $9B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$650M, led by ARK Invest in Jun 2025.
A dated print: it moves only when a newer round is announced.

Both marks are post-money, so 1.70× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

What sector is Abridge in compared to Neuralink?›

Abridge operates in Healthcare technology and AI (AI-powered clinical documentation), and Neuralink operates in Neurotechnology / medical devices.

Which is worth more, Abridge or Neuralink?›

Abridge was last valued at $5.3B in April 2026, and Neuralink at $9B in June 2025.

When did Abridge and Neuralink last raise funding?›

Abridge's most recent round was Series E extension, raising $316M in April 2026; Neuralink's was Series E, raising $650M in June 2025.

Where are Abridge and Neuralink based?›

Abridge is based in Pittsburgh, Pennsylvania, and Neuralink is based in Fremont, California.

Same pillar · company pairs

Neighbouring pairs in this sector

Abridge vs Zocdoccompany pair · health›
$5.3Btop valuation2.9×gap
Abridge vs Innovaccercompany pair · health›
$5.3Btop valuation1.5×gap
Alloy Therapeutics vs Commurecompany pair · health›
$7Btop valuation7.0×gap
Abridge vs HistoSonicscompany pair · health›
$5.3Btop valuation2.4×gap
Benchling vs Pristyn Carecompany pair · health›
$6.1Btop valuation4.4×gap
BioLinq vs Calyxocompany pair · health›
$684.6Mtop valuation1.7×gap
Alloy Therapeutics vs Neuralinkcompany pair · health›
$9Btop valuation9.0×gap
Abridge vs Alloy Therapeuticscompany pair · health›
$5.3Btop valuation5.3×gap
Keep exploring
More pairs in Health
Abridge vs HeartFlowcompare · versus›Abridge vs Commurecompare · versus›Neuralink vs Zocdoccompare · versus›HistoSonics vs Neuralinkcompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

Canborsa

Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.

Markets
Crypto perpetualsStock perpetualsGold & commoditiesIndex perpetualsAll markets ›
Companies
SpaceXOpenAIAnthropicStripeAll companies ›
Compare
Perp feesFunding ratesNo-KYC platformsCanborsa vs AvantisCanborsa vs OstiumAll comparisons ›
Learn
What is a perpetual?Funding rates explainedAirdrops & pointsAll guides ›
© Canborsa 2026TermsPrivacy